| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |